CAFC Decision entered 12 Oct 2018 Affirmed | Mar 20, 2019 | PAPER | BOARD |
Patent Owner's Notice of Appeal to the Court of Appeals for the Federal Circuit | Feb 1, 2017 | PAPER | PATENT OWNER |
Order to Preserve the Record | Jan 17, 2017 | PAPER | BOARD |
Patent Onwer's Unopposed Motion to Preserve the Record Pending Appeal | Jan 13, 2017 | PAPER | PATENT OWNER |
Decision Granting-in-Part Request for Rehearing | Dec 2, 2016 | PAPER | BOARD |
Final Written Decision | Dec 2, 2016 | PAPER | BOARD |
Decision Denying Patent Owner's Motions to Expunge | Oct 5, 2016 | PAPER | BOARD |
Patent Owner's Motion to Expunge Confidential Exhibits | Oct 3, 2016 | PAPER | PATENT OWNER |
Patent Owner's Request for Rehearing | Oct 3, 2016 | PAPER | PATENT OWNER |
VACATED Termination Decision Document | Sep 1, 2016 | PAPER | BOARD |
Record of Oral Hearing | Jun 6, 2016 | PAPER | BOARD |
Petitioners' Objections to Patent Owner's Demonstratives | May 10, 2016 | PAPER | PETITIONER |
Petitioners' Updated Mandatory Disclosures | May 10, 2016 | PAPER | PETITIONER |
Yeda Objections to Petitioners Demonstratives | May 10, 2016 | PAPER | PATENT OWNER |
Order Granting Request for Oral Argument | Apr 28, 2016 | PAPER | BOARD |
Patent Owner's Reply in Support of Motion to Exclude Evidence | Apr 28, 2016 | PAPER | PATENT OWNER |
Petitioners' Reply In Support of Motion to Exclude | Apr 28, 2016 | PAPER | PETITIONER |
Patent Owner's Opposition to Motion to Exclude | Apr 22, 2016 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List IPR2015-00830 | Apr 22, 2016 | PAPER | PATENT OWNER |
Supplemental Certificate of Service | Apr 22, 2016 | PAPER | PATENT OWNER |
Petitioners' Opposition to Patent Owner Motion to Exclude | Apr 22, 2016 | PAPER | PETITIONER |
Sixth Updated Exhibit List | Apr 22, 2016 | PAPER | PETITIONER |
Mylan's Response to Yeda's Observations on Reply | Apr 22, 2016 | PAPER | PETITIONER |
Letter | Apr 22, 2016 | EXHIBIT | PETITIONER |
Letter | Apr 22, 2016 | EXHIBIT | PETITIONER |
Email | Apr 22, 2016 | EXHIBIT | PETITIONER |
Exhibit 2149 | Apr 22, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2150 | Apr 22, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2151 | Apr 22, 2016 | EXHIBIT | PATENT OWNER |
Petitioners' Motion to Exclude | Apr 13, 2016 | PAPER | PETITIONER |
Petitioners' Request for Oral Argument | Apr 13, 2016 | PAPER | PETITIONER |
Patent Owner's Motion to Exclude Evidence | Apr 13, 2016 | PAPER | PATENT OWNER |
Patent Owner's Request for Oral Argument | Apr 13, 2016 | PAPER | PATENT OWNER |
Patent Owner Observations on Cross Examination of Reply Witnesses | Apr 13, 2016 | PAPER | PATENT OWNER |
Petitioners' Fifth Updated Exhibit List | Apr 12, 2016 | PAPER | PETITIONER |
Public Wolinsky Transcript | Apr 12, 2016 | EXHIBIT | PETITIONER |
Dr. Joel Hay Reply Deposition Transcript | Apr 12, 2016 | EXHIBIT | PETITIONER |
Dr. Ari Green Reply Deposition Transcript | Apr 12, 2016 | EXHIBIT | PETITIONER |
Certificate of Service | Mar 22, 2016 | PAPER | PETITIONER |
Declaration of Prof. Joel Hay (Public Version) | Mar 22, 2016 | EXHIBIT | PETITIONER |
Notice of Deposition (Green) | Mar 16, 2016 | PAPER | PATENT OWNER |
Notice of Deposition (Hay) | Mar 16, 2016 | PAPER | PATENT OWNER |
Patent Owner's Objections to Petitioners' Evidence | Mar 16, 2016 | PAPER | PATENT OWNER |
Decision - Patent Owner's Motion to Seal - 37 C.F.R. 42.14 | Mar 15, 2016 | PAPER | BOARD |
Decision - Petitioner's Motion to Seal - 37 C.F.R. 42.14 | Mar 15, 2016 | PAPER | BOARD |
Motion to Seal | Mar 9, 2016 | PAPER | PETITIONER |
Petitioners' Reply Brief | Mar 9, 2016 | PAPER | PETITIONER |
Petitioners' Fourth Updated Exhibit List | Mar 9, 2016 | PAPER | PETITIONER |
Reply Declaration of Ari Green, M.D. | Mar 9, 2016 | EXHIBIT | PETITIONER |
Shared Solutions Website | Mar 9, 2016 | EXHIBIT | PETITIONER |
Gagnon 2008 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Wolinsky 2005 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Khan 2009 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Weber | Mar 9, 2016 | EXHIBIT | PETITIONER |
Hickey 1991B | Mar 9, 2016 | EXHIBIT | PETITIONER |
Stewart | Mar 9, 2016 | EXHIBIT | PETITIONER |
Common Terminology Critera for Advese Events | Mar 9, 2016 | EXHIBIT | PETITIONER |
Singer | Mar 9, 2016 | EXHIBIT | PETITIONER |
McEwan | Mar 9, 2016 | EXHIBIT | PETITIONER |
Bermel | Mar 9, 2016 | EXHIBIT | PETITIONER |
Fisher | Mar 9, 2016 | EXHIBIT | PETITIONER |
LeBano | Mar 9, 2016 | EXHIBIT | PETITIONER |
Declaration of Prof. Joel Hay - PROTECTIVE ORDER MATERIAL | Mar 9, 2016 | EXHIBIT | PETITIONER |
Zhang 2015 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Zhang Poster | Mar 9, 2016 | EXHIBIT | PETITIONER |
Zhang 2014 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Herper | Mar 9, 2016 | EXHIBIT | PETITIONER |
Managed Care Article | Mar 9, 2016 | EXHIBIT | PETITIONER |
Helfand 2015 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Copaxone website | Mar 9, 2016 | EXHIBIT | PETITIONER |
Biogen Press Release | Mar 9, 2016 | EXHIBIT | PETITIONER |
A to Z of MS Article | Mar 9, 2016 | EXHIBIT | PETITIONER |
Osborne | Mar 9, 2016 | EXHIBIT | PETITIONER |
Cohen 2012 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Medicine use and shifting costs of healthcare | Mar 9, 2016 | EXHIBIT | PETITIONER |
Declining Medicine Use and Costs | Mar 9, 2016 | EXHIBIT | PETITIONER |
Valeant Investor Transcript | Mar 9, 2016 | EXHIBIT | PETITIONER |
Orelli | Mar 9, 2016 | EXHIBIT | PETITIONER |
Hefland 2015 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Staton | Mar 9, 2016 | EXHIBIT | PETITIONER |
Frick | Mar 9, 2016 | EXHIBIT | PETITIONER |
MS Treatments Chart | Mar 9, 2016 | EXHIBIT | PETITIONER |
U.S. Pharmaceutical Market, Trends Issues and Outlook | Mar 9, 2016 | EXHIBIT | PETITIONER |
David and Stewart | Mar 9, 2016 | EXHIBIT | PETITIONER |
Maas | Mar 9, 2016 | EXHIBIT | PETITIONER |
Missouri Drug Pricing | Mar 9, 2016 | EXHIBIT | PETITIONER |
Shaw | Mar 9, 2016 | EXHIBIT | PETITIONER |
Morgan Stanley Analyst Report | Mar 9, 2016 | EXHIBIT | PETITIONER |
Copaxone Financial Support Website | Mar 9, 2016 | EXHIBIT | PETITIONER |
Copaxone website | Mar 9, 2016 | EXHIBIT | PETITIONER |
Organization Disclosures | Mar 9, 2016 | EXHIBIT | PETITIONER |
Woods | Mar 9, 2016 | EXHIBIT | PETITIONER |
Anand | Mar 9, 2016 | EXHIBIT | PETITIONER |
Gladwell | Mar 9, 2016 | EXHIBIT | PETITIONER |
Berndt 2002 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Berndt 1995 | Mar 9, 2016 | EXHIBIT | PETITIONER |
Khan, Wayne State | Mar 9, 2016 | EXHIBIT | PETITIONER |
Pinchasi File History | Mar 9, 2016 | EXHIBIT | PETITIONER |
Markman Decision | Mar 9, 2016 | EXHIBIT | PETITIONER |
Stipulation | Mar 9, 2016 | EXHIBIT | PETITIONER |
Congleton Trial Testimony | Mar 9, 2016 | EXHIBIT | PETITIONER |
Ampyra Prescribing Information | Mar 9, 2016 | EXHIBIT | PETITIONER |
Petitioners' Third Updated Exhibit List | Mar 8, 2016 | PAPER | PETITIONER |
Fox Notice | Mar 8, 2016 | EXHIBIT | PETITIONER |
Khan 2009 | Mar 8, 2016 | EXHIBIT | PETITIONER |
Pardo | Mar 8, 2016 | EXHIBIT | PETITIONER |
Bains | Mar 8, 2016 | EXHIBIT | PETITIONER |
Fisher | Mar 8, 2016 | EXHIBIT | PETITIONER |
Fox Declaration | Mar 8, 2016 | EXHIBIT | PETITIONER |
Anderson | Mar 8, 2016 | EXHIBIT | PETITIONER |
Shaw | Mar 8, 2016 | EXHIBIT | PETITIONER |
Ziemssen 2014 | Mar 8, 2016 | EXHIBIT | PETITIONER |
Ziemssen 2015 | Mar 8, 2016 | EXHIBIT | PETITIONER |
Ziemssen QualiCOP | Mar 8, 2016 | EXHIBIT | PETITIONER |
Kleiner | Mar 8, 2016 | EXHIBIT | PETITIONER |
Teva News Release | Mar 8, 2016 | EXHIBIT | PETITIONER |
Aharoni | Mar 8, 2016 | EXHIBIT | PETITIONER |
Patent Owner's Motion to Seal | Mar 7, 2016 | PAPER | PATENT OWNER |
Updated List of Patent Owner's Exhibits | Mar 7, 2016 | PAPER | PATENT OWNER |
Deposition Transcript of Henry G. Grabowski, Ph.D. (Filed Under Seal) | Mar 7, 2016 | EXHIBIT | PATENT OWNER |
Deposition Transcript of Henry G. Grabowski, Ph.D. (Public Version) | Mar 7, 2016 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Mar 1, 2016 | PAPER | PATENT OWNER |
Deposition Transcript of Robert W. Gristwood, Ph.D. | Mar 1, 2016 | EXHIBIT | PATENT OWNER |
Deposition Transcript of Edward J. Fox, M.D. | Mar 1, 2016 | EXHIBIT | PATENT OWNER |
Deposition Transcript of Tjalf Ziemssen | Mar 1, 2016 | EXHIBIT | PATENT OWNER |
DECISION Patent Owner's Motion to Seal | Feb 17, 2016 | PAPER | BOARD |
Decision - Motion for Entry of Protective Order - 37 C.F.R. 42.54 | Feb 12, 2016 | PAPER | BOARD |
Stipulation Regarding Due Dates 2, 4 and 5 | Feb 5, 2016 | PAPER | PETITIONER |
Patent Owner's Updated Exhibit List | Feb 4, 2016 | PAPER | PATENT OWNER |
Exhibit 2133 Corrected Grabowski Declaration FILED UNDER SEAL | Feb 4, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2133 Corrected Grabowski Declaration | Feb 4, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2141 2014.03.03 Morgan Stanley | Feb 4, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2142 U.S. Patent No. 8,377,885 | Feb 4, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2143 2014.04.30 Credit Suisse | Feb 4, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2144 2013.12.12 Credit Suisse | Feb 4, 2016 | EXHIBIT | PATENT OWNER |
Decision - Granting-in-Part and Denying-in-Part Patent Owner's Motion to File Supplemental Information | Feb 1, 2016 | PAPER | BOARD |
Petitioners' Opposition to Patent Owner's Motion to File Supplemental Information | Jan 27, 2016 | PAPER | PETITIONER |
Petitioners' Second Updated Exhibit List | Jan 27, 2016 | PAPER | PETITIONER |
Letter | Jan 27, 2016 | EXHIBIT | PETITIONER |
Protective Order | Jan 27, 2016 | EXHIBIT | PETITIONER |
Jazz Pharma Decision | Jan 27, 2016 | EXHIBIT | PETITIONER |
Transcript of January 21, 2016 Teleconference | Jan 27, 2016 | EXHIBIT | PETITIONER |
Patent Owner's Motion to File Supplemental Information | Jan 22, 2016 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Jan 22, 2016 | PAPER | PATENT OWNER |
Certificate of Service | Jan 22, 2016 | PAPER | PATENT OWNER |
Certificate of Service | Jan 22, 2016 | PAPER | PATENT OWNER |
List of Documents | Jan 22, 2016 | EXHIBIT | PATENT OWNER |
Letter | Jan 22, 2016 | EXHIBIT | PATENT OWNER |
ORDER Conduct of the Proceeding | Jan 21, 2016 | PAPER | BOARD |
Fox Deposition Notice | Jan 15, 2016 | PAPER | PETITIONER |
Ziemssen Deposition Notice | Jan 15, 2016 | PAPER | PETITIONER |
Grabowski Deposition Notice | Jan 10, 2016 | PAPER | PETITIONER |
ORDER Patent Owner's Motions for Pro Hac Vice Admission of Messrs. Benett, Wiesen, and Mitrokostas | Jan 5, 2016 | PAPER | BOARD |
Gristwood Deposition Notice | Jan 4, 2016 | PAPER | PETITIONER |
Decision Granting Institution and Granting Motion for Joinder | Dec 28, 2015 | PAPER | BOARD |
Motion for Pro Hac Vice Admission | Dec 21, 2015 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Dec 21, 2015 | PAPER | PATENT OWNER |
2138 | Dec 21, 2015 | EXHIBIT | PATENT OWNER |
Motion for Pro Hac Vice Admission | Dec 18, 2015 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Dec 18, 2015 | PAPER | PATENT OWNER |
2137 | Dec 18, 2015 | EXHIBIT | PATENT OWNER |
Motion for Pro Hac Vice Admission | Dec 10, 2015 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Dec 10, 2015 | PAPER | PATENT OWNER |
2136 | Dec 10, 2015 | EXHIBIT | PATENT OWNER |
Petitioner's Objections to Patent Owner Evidence | Dec 3, 2015 | PAPER | PETITIONER |
Motion to Seal | Nov 25, 2015 | PAPER | PATENT OWNER |
Stipulated Motion for Entry of Protective Order | Nov 25, 2015 | PAPER | PATENT OWNER |
Updated List of Patent Owner's Exhibits | Nov 25, 2015 | PAPER | PATENT OWNER |
Yeda Patent Owner Response | Nov 25, 2015 | PAPER | PATENT OWNER |
Corrected Mckeage (2015) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Comi (2008) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Wolinsky (2015) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Farina | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
PRA (2012) Peroutka Dep. Ex. 4 | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
11-cv-00717 Document 226 Peroutka Dep. Ex. 6 | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Oksebberg (1992) Peroutka Dep. Ex. 9 | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Shalit (1996) Peroutka Dep. Ex. 12 | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
11-cv-00717 Document 310- Peroutka Dep. Ex. 15 | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Fridkis-Hareli (1999) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Abandonment APN 11/651,212 | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Meibohm (1997) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Lambert (2008) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Glenn (2003) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Partidos (2003) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Ghose (2007) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Glenn (1998) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Aharoni (2000) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Arnon (2004) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Varkony (2009) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Comi (2002) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Chabot (2002) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Ziemssen (2004) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Schmeisser (2000) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Efimova (2005) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Toutain (2004) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Ryan (1997) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Levi-Schaffer abstract (1996) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Imming (2006) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Pert (1973) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Petty (1994) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Peroutka (1988) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Hestvik (2008) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Aharoni (2013) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Burger (2009) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Mendes (2011) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Aharoni (1997) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Aharoni (1998) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Neuhaus (2001) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Ziemssen (2002) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Miller (1998) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Neuhaus (2000) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Duda (2000) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Hori (2003) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Brunkow (2001) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Viglietta (2004) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Hong (2005) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Wekerle (1986) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Hickey (1999) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Weber (2004) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Menge (2008) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Sodoyez (1980) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Wroblewski (1991) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Monro (1993) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
ONeil (1997) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Beer (2011) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Ziemssen (2007) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Ziemssen (2005) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Ziemssen (2008) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Pharmacology (2005) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Paty (1994) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Fisniku (2008) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Kahn (2013) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Rumrill (2009) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Katz (2003) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Zellner (2005) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Castells (2009) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Gala Brain Loss (2015) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Shalit (2009) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Wynn (2015) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Avonex (2008) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Rebif (2009) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Extavia (2009) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Edward J. Fox. MD., PhD., FAAN | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Sorensen (2003) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Vijlder (2002) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Lee (1990) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Henry George Grabowski | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
List of Testimony of Henry G. Grabowski | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Documents Relied Upon (Grabowski) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Approval Timeline, Multiple Sclerosis Drugs | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Wholesale Dollar Sales | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Wholesale Dollar Sales | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Extended Units | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Extended Units | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Total Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Total Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
New Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
New Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Drugs Share of Wholesale Dollar Sales | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Drugs Share of Wholesale Dollar Sales | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Drugs Share of Total Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Drugs Share of Total Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Drugs Share of New Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Drugs Share of New Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Rationale for Requesting Copaxone | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Perception of 3-times-a-week | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Rationale for Discussing 20mg and 40mg | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Perceptions of Copaxone | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Perceptions of Copaxone | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Total Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Total Prescriptions | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Net Prescriptions Flow | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Net Prescriptions Flow | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Total Promotional Spending to Sales Ratio | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Total Promotional Spending to Sales Ratio | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Comi (2009) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Valenzuela (2007) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Blanco (2006) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Chen (2002) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Chen (1991) | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
D23 end of story press release | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Declaration of Edward J. Fox, MD., PhD | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Robert William Gristwood PhD | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Curriculum Vitae Tjalf Ziemssen | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Ziemssen MS clinical trials | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Declaration of Henry G. Grabowski, Ph.D. | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Declaration of Henry G. Grabowski, Ph.D. | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Declaration of Robert William Gristwood, Ph.D. | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Declaration of Tjalf Ziemssen, M.D., Ph.D | Nov 25, 2015 | EXHIBIT | PATENT OWNER |
Updated List of Petitioner's Exhibits | Nov 18, 2015 | PAPER | PETITIONER |
Deposition of Dr. Ari Green | Nov 18, 2015 | EXHIBIT | PETITIONER |
Deposition of Dr. Stephen Peroutka | Nov 18, 2015 | EXHIBIT | PETITIONER |
Mylan's Updated Mandatory Notices | Oct 20, 2015 | PAPER | PETITIONER |
Order - Petitioner's Motions for Pro Hac Vice Admission of David L. Anstaett and Shannon M. Bloodworth | Oct 19, 2015 | PAPER | BOARD |
Notice of Deposition (Green) | Oct 19, 2015 | PAPER | PATENT OWNER |
Notice of Deposition (Peroutka) | Oct 19, 2015 | PAPER | PATENT OWNER |
Pro Hac Vice Motion for David Anstaett | Oct 8, 2015 | PAPER | PETITIONER |
Pro Hac Vice Motion for Shannon Bloodworth | Oct 8, 2015 | PAPER | PETITIONER |
IPR2015-00830 Patent Owner Objections to Pre-Institution Evidence | Sep 16, 2015 | PAPER | PATENT OWNER |
Petitioner's Objections to Evidence Submitted by Patent Owner | Sep 16, 2015 | PAPER | PETITIONER |
Decision - Institution of Inter Partes Review - 37 C.F.R. 42.108 | Sep 1, 2015 | PAPER | BOARD |
Scheduling Order | Sep 1, 2015 | PAPER | BOARD |
Power of Attorney | Aug 18, 2015 | PAPER | PATENT OWNER |
Yeda's Patent Owner Preliminary Response | Jun 19, 2015 | PAPER | PATENT OWNER |
2001_FORTE | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2002_Quintanna | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2003_Virley | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2004_Friese | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2005_Copaxone Prescrib | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2006_Teitelbaum | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2007_Conner | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2008_PDR | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2009_Schrempf | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2010_Yong | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2011_Dhib | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2012_Neuhaus | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2013_Abramsky | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2014_Bornstein | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2015_Borenstein 1982 | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2016_Bornstein 1987 | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2017_Sage | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2018_Filippi | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2019_Ramot | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2020_US20070161566 | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2021_Ziemssen | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2022_Teva Press Release | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2023_ Khan | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2024_Q1-15 PR English | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2025_McKeage | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2026_Johnson | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
2027_Dictionary | Jun 19, 2015 | EXHIBIT | PATENT OWNER |
Power of Attorney | Mar 24, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Related Matters | Mar 24, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Notice of Filing Date Accorded to Petition | Mar 19, 2015 | PAPER | BOARD |
Power of Attorney | Mar 3, 2015 | PAPER | PETITIONER |
Petition for Inter Partes Review of U.S. Patent No. 8,969,302 | Mar 3, 2015 | PAPER | PETITIONER |
U.S. Patent No. 8,969,302, LOW FREQUENCY GLATIRAMER ACETATE THERAPY (filed February 19, 2013) (issued March 3, 2015) | Mar 3, 2015 | EXHIBIT | PETITIONER |
File History for U.S. Patent No. 8,969,302 | Mar 3, 2015 | EXHIBIT | PETITIONER |
Declaration of Stephen J. Peroutka, M.D., Ph.D. and Curriculum Vitae of Stephen J. Peroutka, M.D., Ph.D. | Mar 3, 2015 | EXHIBIT | PETITIONER |
Expert Declaration of Ari Green, M.D. and Curriculum Vitae | Mar 3, 2015 | EXHIBIT | PETITIONER |
International Publication No. WO 2007/081975 | Mar 3, 2015 | EXHIBIT | PETITIONER |
Cohen et al., Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS, 68, 12 NEUROLOGY, 939-44 (2007) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Affidavit of Marlene S. Bobka dated December 9, 2014 Jessop Review and Evaluation | Mar 3, 2015 | EXHIBIT | PETITIONER |
Flechter 2002A Copolymer 1 (Glatiramer Acetate) in Relapsing Forms of Multiple Sclerosis | Mar 3, 2015 | EXHIBIT | PETITIONER |
Meiner et al., Copolymer 1 in Relapsing-Remitting Multiple Sclerosis | Mar 3, 2015 | EXHIBIT | PETITIONER |
Khan et al., Randomized, Prospective, Rater-Blinded, Four-Year | Mar 3, 2015 | EXHIBIT | PETITIONER |
Caon et al., Randomized, Prospective, Rater-Blinded, Four Year Pilot Study | Mar 3, 2015 | EXHIBIT | PETITIONER |
Flechter 2002B Comparison of glatiramer acetate (Copaxone) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Miller, The importance of early diagnosis of multiple sclerosis | Mar 3, 2015 | EXHIBIT | PETITIONER |
Bornstein, Multiple Sclerosis Trial of a Synthetic Polypeptide, 11,3 ANNALS OF NEUROLOGY, 317-19 (1982) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Bornstein et al., Clinical Trial of Copolymer I in Multiple Sclerosis, 436 ANNALS NEW YORK ACADEMY OF SCIENCES, 366-372 (1984) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Bornstein et al., A Pilot Trial of COP 1 in Exacerbating-Remitting Multiple Sclerosis (1987) | Mar 3, 2015 | EXHIBIT | PETITIONER |
FDA, GUIDELINE FOR INDUSTRY, Dose-Response Information to Support Drug Registration (1994) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Johnson et al., Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis, 43 NEUROLOGY, 1268-1276 (1995) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Affidavit of Marlene S. Bobka dated January 5, 2015 1996 FDA Meeting Agenda minutes from the Peripheral and Central Nervous System Drug Advisory Committee | Mar 3, 2015 | EXHIBIT | PETITIONER |
Arnon, The Development of Cop 1(Copaxone) 50 IMMUNOLOGY LETTERS 1-15 (1996) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Benet et al., Pharmacokinetics The Dynamics of Drug Absorption, Distribution, and Elimination, in THE PHARMACOLOGICAL BASIS OF THERAPEUTICS, 3 (Alfred Goodman Gilman ed. 1996) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Lobel, et al., Copolymer-1, 21(2) DRUGS OF THE FUTURE, 131-134 (1996) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Haines et al., Linkage of the MHC to Familial Multiple Sclerosis Suggests Genetic Heterogeneity. HUM. MOL. GENET. 7,1229-34 (Aug 1998) | Mar 3, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,342,476, Copolymer-1 Improvements in Compositions of Copolymers (2002). | Mar 3, 2015 | EXHIBIT | PETITIONER |
Ge et al., Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS Quantitative MR Assessment, 54 NEUROLOGY, 813-17 (2000) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Comi et al., European/Canadian Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Glatiramer Acetate 49, 3 ANN. NEUROL., 290-97 (2001) | Mar 3, 2015 | EXHIBIT | PETITIONER |
McDonald et al., Recommended Diagnostic Criteria for Multiple Sclerosis, Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis, ANN. NEUROL. 50,121-27 (2001) | Mar 3, 2015 | EXHIBIT | PETITIONER |
McBride, Second International Multiple Sclerosis Week Multiple Sclerosis, INTL J. MS CARE 4, 85 (2002) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Simpson, Adis Drug Evaluation Glatiramer Acetate 16, 12 CNS DRUGS, 825-50, 834 (2002) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Edgar, Lipoatrophy in Patients with Multiple Sclerosis on Glatiramer Acetate, 31 CAN. J. NEUROL. SCI., 58-63 (2004) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Ziemssen, Effects of Glatiramer Acetate on Fatigue and Days of Absence from Work in First-Time Treated Relapsing-Remitting Multiple Sclerosis, HLTH. and QUAL. LIFE OUTCOMES 6, 67 (2008) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Stuart, Clinical Management of Multiple Sclerosis, The Treatment Paradigm and Issues of Patient Management, J. MANAGED CARE PHARMACY 10, S19-S25 (June 2004) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Bakshi, Imaging of Multiple Sclerosis, Role in Neurotherapeutics, 2, 2 NEURORX, 277 (2005) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Beringer, Clinical Pharmacokinetics and Pharmacodynamics, in REMINGTON, THE SCIENCE AND PRACTICE OF PHARMACY, 1191 (Beringer ed., 2005) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Franklin, Drug Absorption, Action, and Disposition, in REMINGTON THE SCIENCE AND PRACTICE OF PHARMACY, 1142 (Beringer ed., 2005) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Rasmussen, International Patent Publication No. WO 2005/120542 A2 (December 22, 2005) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Devonshire, The Global Adherence Project A Multicentre Observational Study, MULTIPLE SCLEROSIS 12, S1 (P316) (2006) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Ford, A Prospective Open-Label Study of Glatiramer Acetate, 12 MULTIPLE SCLEROSIS, 309-320 (2006) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Frohman, Multiple Sclerosis, The Plaque and its Pathogenesis, NEW ENGLAND J. MED. 354, 942-55 (2006) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Kragt, How Similar are Commonly Combined Criteria for EDSS Progression in Multiple Sclerosis 12(6) MULTIPLE SCLEROSIS 782 (2006) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Manso, Life Cycle Management of Ageing Pharmaceutical Assets, 3 PHARMACEUTICAL LAW INSIGHT, (2006) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Soares, Localized Panniculitis Secondary to Subcutaneous Glatiramer Acetate Injections for the Treatment of Multiple Sclerosis, J. AM. ACAD. DERM. 55, 968 (2006) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Klauer, Compliance, Adherence and the Treatment of Multiple Sclerosis, J. NEUROL. 255, Suppl. 6, (2008) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Pelidou, Multiple Sclerosis Presented as Clinically Isolated Syndrome THER. CLIN. RISK MANAGEMENT 4, 627-30 (June 2008) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Jacobs, Intramuscular interferon beta-1a therapy NEW ENGL. J. MED. 343, 898-904 (2008) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Teva Provides Update on Forte Trial Jerusalem, Israel (July 7, 2008) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Copaxone U.S. Product Label (2001) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Betaseron U.S. Product Label (2003) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Rebif U.S. Product Label (2003) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Avonex Product Label (2006) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Tysabri Product Label (2008) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Copaxone U.S. Product Label (Feb. 2009) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Extavia Product Label (2009) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Rebif Product Label (June 2005) | Mar 3, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. Patent 3,849,550, THERAPEUTIC COPOLYMER (filed March 31, 1972) (issued November 19, 1974) | Mar 3, 2015 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2009/0149541A1 (filed Nov. 26, 2008) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Concepts in Clinical Pharmacokinetics, in INTRODUCTION TO PHARMACOKINETICS AND PHARMACODYNAMICS, Tozer and Rowland eds (Lippincott Williams and Wilkins 2006) | Mar 3, 2015 | EXHIBIT | PETITIONER |
Rich, Stepped-Care Approach to Treating MS, J. MANAGED CARE PHARM. 10, S26-S32 (June 2004) | Mar 3, 2015 | EXHIBIT | PETITIONER |
FDA GUIDANCE FOR INDUSTRY - POPULATION PHARMACOKINETICS (1999) | Mar 3, 2015 | EXHIBIT | PETITIONER |
U.S. Published Patent Application No. US 2013/0165387, LOW FREQUENCY GLATIRAMER ACETATE THERAPY (published June 27, 2013) | Mar 3, 2015 | EXHIBIT | PETITIONER |